Loading
Viral Infections and Vectors / Viral Infections and Outbreaks Research / Vector Borne Animal Diseases · Journal article
International Journal of Community Medicine and Public Health · July 31, 2026
A consensus or society position rather than new primary data.
This is an expert narrative review and guidance document on hantavirus epidemiology, emphasizing the 2026 Andes virus outbreak as a case study for international dissemination risk and highlighting surveillance and diagnostic gaps in India. The authors recommend strengthening one health surveillance, laboratory capacity, rodent monitoring, genomic sequencing, and clinician awareness as preparedness measures.
Journal article. Global hantavirus epidemiology with focus on India; reference to 2026 Andes virus outbreak affecting multiple countries.. Global focus with emphasis on India; reference to 2026 Andes virus outbreak affecting multiple countries and expedition cruise ship MV Hondius..
The 2026 multinational Andes virus outbreak linked to expedition cruise ship MV Hondius resulted in multiple cases, deaths, and large-scale cross-border public health responses. Two major hantavirus clinical syndromes are recognized globally: hemorrhagic fever with renal syndrome (HFRS) in Asia and Europe, and Hantavirus cardiopulmonary syndrome (HCS) in the Americas. India has ecological conditions favorable for hantavirus circulation and documented evidence of hantavirus-related viruses, but the apparent absence of major outbreaks may reflect surveillance and diagnostic gaps rather than true disease absence.
The 2026 outbreak is described narratively; specific case counts, mortality figures, and attack rates are not reported.
Clinicians and public health practitioners should be aware of hantavirus as an emerging zoonotic threat in India despite current apparent disease absence, and should maintain diagnostic suspicion given documented evidence of hantavirus-related viruses and favorable ecological conditions. Preparedness requires strengthened surveillance, laboratory diagnostics, and genomic capacity.
This is a narrative review and expert commentary on hantavirus epidemiology, surveillance gaps, and preparedness recommendations for India, not a primary research study with quantified evidence.
As stated by the source record.
Clinicians and public health practitioners should be aware of hantavirus as an emerging zoonotic threat in India despite current apparent disease absence, and should maintain diagnostic suspicion given documented evidence of hantavirus-related viruses and favorable ecological conditions. Preparedness requires strengthened surveillance, laboratory diagnostics, and genomic capacity.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Hantaviruses are emerging zoonotic pathogens of the family Hantaviridae that are present in rodent and insectivore reservoirs. They are transmitted primarily through inhalation of contaminated aerosols. Globally, it causes two major clinical syndromes: hemorrhagic fever with renal syndrome (HFRS), predominantly in Asia and Europe and Hantavirus cardiopulmonary syndrome (HCS), primarily seen in the Americas. The 2026 multinational Andes virus Outbreak linked to the expedition cruise ship MV Hondius demonstrated the potential for rapid international dissemination of Hantavirus through global travel, resulting in multiple cases, deaths, and large-scale cross-border public health responses. The outbreak highlighted the importance of genomic surveillance, international collaboration, contact tracing, and preparedness for emerging zoonotic threats. India possesses ecological conditions favorable for hantavirus circulation and has documented evidence of hantavirus-related viruses. The apparent absence of major hantavirus outbreaks in India may reflect surveillance and diagnostic gaps rather than the true absence of disease. Strengthening one health surveillance, laboratory capacity, rodent monitoring, genomic sequencing, and clinician awareness is essential to enhance preparedness against emerging hantavirus threats.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.